The iTRAQ reagents were first launched at ASMS 2004 and quickly became adopted as a powerful mainstream proteomics technique. The ease-of-use of this reagent based strategy has meant that accurate quantitative proteomics is now within the reach of all biological scientists. This technical note is not meant to be an exhaustive list of all of the publications involving the iTRAQ reagents, but rather an overview of papers where the iTRAQ reagents have been used to make breakthrough discoveries and advance biological research.
Comparative proteome analysis of human epithelial ovarian cancer.
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